Expression of Serum sLOX-1 in Patients with Non-Small-Cell Lung Cancer and Its Correlation with Lipid Metabolism

Figure 1

Expression levels of sLOX-1, LDL, HDL, and TG in serum of patients with NSCLC stage I–II and stage III–IV. ns: no significance. < 0.01.  < 0.001.

(a)

(b)

(c)

(d)